These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15731908)

  • 1. The effect of the 5-chloro-2-methylthio-6-(1-naphtyloxy)-1H-benzimidazole on the tegument of immature Fasciola hepatica in their natural host.
    Rivera N; Ibarra F; Zepeda A; Fortoul T; Cantó G; Hernández A; Castillo R
    Parasitol Res; 2005 Apr; 95(6):379-82. PubMed ID: 15731908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tegumental surface changes in adult Fasciola hepatica following treatment in vitro and in vivo with an experimental fasciolicide.
    Rivera N; Ibarra F; Zepeda A; Fortoul T; Hernández A; Castillo R; Cantó G
    Parasitol Res; 2004 Jul; 93(4):283-6. PubMed ID: 15160287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitol Res; 2007 Jan; 100(2):365-77. PubMed ID: 17016729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.
    Meaney M; Fairweather I; Brennan GP; McDowell LS; Forbes AB
    Parasitol Res; 2003 Oct; 91(3):238-50. PubMed ID: 12937959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Castillo R; Hernández-Campos A; Fairweather I
    Parasitology; 2009 May; 136(6):665-80. PubMed ID: 19368745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica: disruption of spermatogenesis by the fasciolicide compound alpha.
    McConville M; Hanna RE; Brennan GP; McCoy M; Edgar HW; McConnell S; Castillo R; Hernández-Campos A; Fairweather I
    Parasitol Res; 2010 Jan; 106(2):311-23. PubMed ID: 19921260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the effective dose of an experimental intramuscular formulation against immature and adult Fasciola hepatica in sheep.
    Ibarra-Velarde F; Vera-Montenegro Y; Flores-Ramos M; Cantó-Alarcon GJ; Hernández-Campos A; Alcala-Canto Y; Castillo R
    Vet Parasitol; 2018 Aug; 260():38-44. PubMed ID: 30197011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the effective dose of an experimental fasciolicide in naturally and experimentally infected cattle.
    Ibarra F; Vera Y; Quiroz H; Cantó J; Castillo R; Hernández A; Ochoa P
    Vet Parasitol; 2004 Feb; 120(1-2):65-74. PubMed ID: 15019144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Hanna RE; Edgar HW; Castillo R; Hernández-Campos A; Fairweather I
    Parasitol Res; 2009 Sep; 105(3):757-67. PubMed ID: 19458965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Sep; 172(3-4):238-48. PubMed ID: 20627418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).
    McKinstry B; Fairweather I; Brennan GP; Forbes AB
    Parasitol Res; 2003 Oct; 91(3):251-63. PubMed ID: 12937960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and fasciolicidal activity of 5-chloro-2-methylthio-6-(1-naphthyloxy)-1H-benzimidazole.
    Hernández-Campos A; Ibarra-Velarde F; Vera-Montenegro Y; Rivera-Fernández N; Castillo R
    Chem Pharm Bull (Tokyo); 2002 May; 50(5):649-52. PubMed ID: 12036021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).
    Stitt AW; Fairweather I
    Parasitol Res; 1993; 79(7):529-36. PubMed ID: 8278333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
    Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent changes to the tegumental system and gastrodermis of adult Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2010 Dec; 174(3-4):218-27. PubMed ID: 20933333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.